Pfizer (PFE) in Global Blood Therapeutics (GBT) Takeover Talks
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
GBT Announces New Employment Inducement Grants
August 4, 2022 4:05 PM EDTSOUTH SAN FRANCISCO, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc.(GBT) (NASDAQ: GBT) today announced that on August 1, 2022, the compensation committee of GBTs board of directors granted 10 new employees restricted stock units for an aggregate of 30,450 shares of the companys common stock. These awards were made under GBTs Amended and Restated 2017 Inducement Equity Plan (the Plan).Â
The above-described awards were... More
